Filana Therapeutics, Inc. (FLNA)
0.9501
+0.02
(+2.16%)
USD |
NASDAQ |
Aug 25, 12:24
Filana Therapeutics Shareholders Equity (Quarterly) : 63.61M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 63.61M |
| March 31, 2026 | 68.14M |
| December 31, 2025 | 74.40M |
| September 30, 2025 | 81.57M |
| June 30, 2025 | 87.97M |
| March 31, 2025 | 127.62M |
| December 31, 2024 | 145.70M |
| September 30, 2024 | 166.64M |
| June 30, 2024 | 188.97M |
| March 31, 2024 | 78.60M |
| December 31, 2023 | 137.47M |
| September 30, 2023 | 155.12M |
| June 30, 2023 | 179.35M |
| March 31, 2023 | 204.00M |
| December 31, 2022 | 227.54M |
| September 30, 2022 | 198.72M |
| June 30, 2022 | 218.37M |
| March 31, 2022 | 237.09M |
| December 31, 2021 | 253.92M |
| September 30, 2021 | 267.56M |
| June 30, 2021 | 276.48M |
| March 31, 2021 | 281.19M |
| December 31, 2020 | 92.20M |
| September 30, 2020 | 23.97M |
| June 30, 2020 | 24.18M |
| Date | Value |
|---|---|
| March 31, 2020 | 24.83M |
| December 31, 2019 | 22.10M |
| September 30, 2019 | 17.44M |
| June 30, 2019 | 17.82M |
| March 31, 2019 | 18.55M |
| December 31, 2018 | 19.63M |
| September 30, 2018 | 19.97M |
| June 30, 2018 | 8.546M |
| March 31, 2018 | 10.30M |
| December 31, 2017 | 9.699M |
| September 30, 2017 | 11.37M |
| June 30, 2017 | 13.27M |
| March 31, 2017 | 16.72M |
| December 31, 2016 | 18.64M |
| September 30, 2016 | 20.32M |
| June 30, 2016 | 22.99M |
| March 31, 2016 | 25.28M |
| December 31, 2015 | 29.37M |
| September 30, 2015 | 33.07M |
| June 30, 2015 | 35.94M |
| March 31, 2015 | 38.44M |
| December 31, 2014 | 40.06M |
| September 30, 2014 | 41.21M |
| June 30, 2014 | 43.65M |
| March 31, 2014 | 45.70M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CorMedix, Inc. | 460.83M |
| Eloxx Pharmaceuticals, Inc. | 46.42M |
| Cannabis Global, Inc. | -4.772M |
| Breakthrough Chemistry, Inc. | 0.8373M |
| BioStem Technologies, Inc. | 27.61M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 103.90M |
| Total Liabilities (Quarterly) | 40.29M |
| Current Ratio | 2.085 |